Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotage has launched a new microwave and parallel peptide synthesizer Syro Wave, under the joint development project announced last year with MultiSynTech. Syro Wave combines the performance of the MultiSynTech robotic synthesizer with Biotage microwave technology.
Subscribe to our email newsletter
The Syro Wave peptide synthesis system offers both microwave and parallel peptide synthesis capabilities.
Biotage said that to date peptide synthesis labs have been required to invest in both standalone parallel systems for productivity and cost efficiency, and standalone microwave systems for difficult or longer peptides.
This results in increased demand on bench space, duplication of computer control systems, and multiple operating software platforms for chemists to learn and maintain. Biotage has addressed these shortcomings with the Syro Wave, containing both parallel and microwave technologies on the same platform.
Scott Carr, vice president of commercial operations at Biotage, said: The new Biotage Syro Wave increases productivity, yield and purity while cutting costs and saving time. At Biotage the focus is on developing technology to speed up and simplify experimental procedures while simultaneously driving down operating costs. Whether the customer is a Pharma development group, a CRO focused on cost and productivity or an Academic researcher focused on unique sequences, the Syro Wave fits.”